Countless patients died last year due to inability to access trials, says Cell Therapies CEO.
MSD, Pfizer tipped to lead M&A activity in 2021 as AbbVie reported to be looking to sell off $6.5 billion women’s health portfolio.
One million vaccines a week set to be delivered says Health Minister.
BMS came, saw and conquered Australia’s highest mountain on Saturday, arriving from Melbourne with a team of 42 people and returning to their Victorian headquarters with the highly coveted Pharma Cup.
Six funding knockbacks prompts Aussie company to rethink access, leading to a potentially new way of funding health innovations.
Melanoma survivor Jay Allen was awarded an Order of Australia in January for raising awareness of the cancer but now the father of six is facing another battle.
Attempt to include carer costs in economic modelling for cannabis-derived drug not positively received.
‘Disappointed’ at being pushed into a Risk Sharing Agreement for low-cost, Aussie-made product.